During pregnancy, CAV1 has been associated with glucose and fatty acid transport in the placenta by inducing AMPK and reducing the GLUT1 signalling pathway and reversing macrosomia due to gestational diabetes (GD) [74]. This evidence concerns the gene SLC2A1 and gestational diabetes.